Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
971.00    -14.00 (-1.42%)
Bid:
980.20
Ask:
980.60
Spread: 0.40 (0.041%)
Market Cap: £4.75b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Transaction in Own Shares

10 Dec 2025 07:00

RNS Number : 9020K
Babcock International Group PLC
10 December 2025
 

Babcock International Group PLC - Transaction in Own Shares

 

10 December 2025

 

Transaction in Own Shares

 

Babcock International Group PLC (the Company) announces today it has purchased the following number of its ordinary shares of 60 pence each through Jefferies International Limited.

Date of purchase:

09 December 2025

Aggregate number of ordinary shares purchased:

15

Highest price paid per share (£ per share):

11.9600

Lowest price paid per share (£ per share):

11.9300

Volume weighted average price paid per share (£):

11.9533

The Company intends to hold the purchased shares in treasury.

Since 24 July 2025, the Company has purchased 7,560,806 shares at a cost of £83,755,739.55.

Following the above transaction, the Company holds 5,757,846 of its ordinary shares in treasury and has 499,838,751 ordinary shares in issue (excluding treasury shares).

The table below contains detailed information about the purchases referred to above.

Schedule of purchases

 

Shares purchased:

Babcock International Group PLC (ISIN: GB0009697037)

Date of purchases:

09 December 2025

Investment firm:

Jefferies International Limited

Aggregate information

 

Venue

Aggregated number of ordinary shares purchased

Volume-weighted average price per share (£)

Lowest price per share (£)

Highest priceper share (£)

London Stock Exchange

15

11.9533

11.9300

11.9600

CBOE CXE

0

0.0000

0.0000

0.0000

CBOE BXE

0

0.0000

0.0000

0.0000

Turquoise

0

0.0000

0.0000

0.0000

Aquis

0

0.0000

0.0000

0.0000

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 (as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018), a full breakdown of the individual trades made by Jefferies International Limited on behalf of the Company is set out below.

Transaction Time

Time Zone

Volume

Price

Currency

Platform Code

Transaction reference number

 

15:43:10

GMT

10

11.960

GBP

XLON

00503658682TRLO1.1.1

15:43:10

GMT

1

11.960

GBP

XLON

00503658683TRLO1.1.1

15:51:40

GMT

1

11.950

GBP

XLON

00503663283TRLO1.1.1

15:54:31

GMT

1

11.930

GBP

XLON

00503664741TRLO1.1.1

15:54:31

GMT

2

11.930

GBP

XLON

00503664740TRLO1.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFFDFSLAIIE
Date   Source Headline
26th Jul 20247:00 amRNSFull year results for the year ended 31 March 2024
17th Jul 20247:00 amRNSFY24 results update and Type 31 contract update
7th Jun 20247:00 amRNSHolding(s) in Company
26th Apr 20241:15 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSContract awarded to refit UK nuclear submarine
21st Feb 20245:58 pmRNSDirector/PDMR Shareholding
15th Feb 20247:05 amRNSDirector announcement
14th Feb 20245:36 pmRNSDirector/PDMR Shareholding
14th Feb 20249:00 amRNSDirector appointment
9th Feb 20244:26 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSCapital Markets Day
6th Feb 20244:58 pmRNSDirector/PDMR Shareholding
5th Feb 202411:29 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAmended Capital Markets Day start time
12th Jan 20247:00 amRNSNotice of Capital Markets Day
15th Dec 20234:51 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
10th Nov 202312:00 pmRNSBabcock signs £750 million infrastructure contract
7th Nov 20233:24 pmRNSHolding(s) in Company
30th Oct 20231:55 pmRNSHolding(s) in Company
28th Sep 20236:12 pmRNSResult of AGM
28th Sep 20237:00 amRNSAGM trading update
26th Sep 20235:57 pmRNSHolding(s) in Company
26th Sep 20235:56 pmRNSHolding(s) in Company
22nd Aug 20238:54 amRNSDirector/PDMR Shareholding
17th Aug 20232:52 pmRNSNotice of AGM
16th Aug 20235:16 pmRNSDirector/PDMR Shareholding
9th Aug 202310:00 amRNSDirector/PDMR Shareholding
4th Aug 20233:24 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:34 pmRNSDirector/PDMR Shareholding
3rd Aug 202310:19 amRNSDirector/PDMR Shareholding
2nd Aug 20233:25 pmRNSDirector/PDMR Shareholding
2nd Aug 202310:22 amRNSDirector/PDMR Shareholding
31st Jul 20239:22 amRNSAnnual Financial Report
20th Jul 20237:16 amRNSFull year results for the year ended 31 March 2023
11th Jul 20237:00 amRNSDate of publication of FY23 preliminary statement
24th May 20238:54 amRNSDirectorate Change
20th Apr 20237:00 amRNSFY23 post close update and Type 31 contract update
1st Mar 20237:00 amRNSDisposal programme successfully concluded
15th Feb 20239:09 amRNSBabcock awarded contract to operate Skynet
2nd Feb 20238:13 amRNSDirectorate Change
20th Dec 202212:54 pmRNSStandard & Poor credit rating upgrade
9th Dec 20229:29 amRNSHolding(s) in Company
8th Dec 20229:06 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSHalf-year Report
9th Nov 20224:48 pmRNSHolding(s) in Company
3rd Nov 202212:13 pmRNSRestatement of pass-through revenue for HY22
3rd Nov 202211:08 amRNSRestatement of H1 2022 Results
21st Oct 20228:05 amRNSContract Win
18th Oct 20229:00 amRNSDirector appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.